Nevertheless, according to the literature, COMMD3 is expressed at a high level in prostate cancer, enhances migratory and invasiveness properties of tumor cells, and is also associated with tumor recurrence and low survival rate [30]. This evidence concerns the gene COMMD3 and prostate carcinoma.